new weight loss drug retatrutide (“reta”) is an experimental weight-loss currently in Phase 3 clinical trials. It's a once-weekly injection similar to Ozempic and Mounjaro—but more powerful. The reason comes down to how it works Retatrutide FDA Approval Status 2026:

Important Notice: This product is intended solely for laboratory research and development purposes

Promotes healthy metabolism for effective weight management

Over-the-counter antacids or proton pump inhibitors may help, but contact your healthcare provider if symptoms are severe or persistent

12 As this confers a much longer half-life than that of native sequence GLP-1 (hours rather than minutes), the development of GLP-1 RAs has proceeded down two paths: as analogues of either human GLP-1, or of exendin-4

Numbness or tingling in the hands and feet

[1] Homosynaptic plasticity is input-specific, meaning changes in synapse strength occur only at post-synaptic targets specifically stimulated by a pre-synaptic target